Immunomedics Inc - Company Profile
Powered by 
All the data and insights you need on Immunomedics Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Immunomedics Inc Strategy Report
- Understand Immunomedics Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Immunomedics Clinical Trials
Determine Immunomedics Inc go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.
A sample of Immunomedics Clinical Trials data
| Trial Title | Trial Identifier | Drug Name | Therapy Area | Indication | Trial Phase | Trial Status | Sponsor |
|---|---|---|---|---|---|---|---|
| Deserunt mollit sunt Lorem | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Pfizer Inc |
| An Phase II, Open-label, Sequential-Arm Study of Sacituzumab Govitecan and Sacituzumab Govitecan plus Pembrolizumab Before Radical Cystectomy in Subjects with Muscle-invasive Bladder Cancer (MIBC) | GDCT0413642 | pembrolizumab; sacituzumab govitecan | Oncology | Bladder Cancer; Bladder Carcinoma; Muscle Invasive Bladder Cancer (MIBC) | Phase II | Ongoing, recruiting | IRCCS San Raffaele Hospital |
| Sacituzumab Govitecan Plus EV in Metastatic UC | GDCT0411297 | enfortumab vedotin; sacituzumab govitecan | Oncology | Bladder Cancer; Metastatic Transitional (Urothelial) Tract Cancer; Transitional Cell Cancer (Urothelial Cell Cancer); Ureter Cancer; Urethral Cancer | Phase I | Ongoing, recruiting | Dana-Farber Cancer Institute Inc |
| Testing Sacituzumab Govitecan Therapy in Patients With HER2-Negative Breast Cancer and Brain Metastases | GDCT0406341 | sacituzumab govitecan | Oncology | Brain Cancer; Breast Cancer; Human Epidermal Growth Factor Receptor 2 Negative Breast Cancer (HER2- Breast Cancer); Malignant Neoplasms; Metastatic Breast Cancer | Phase II | Ongoing, recruiting | The Southwest Oncology Group Statistical Center |
Feature
GlobalData’s Clinical Trials database (CTDB) is a highly comprehensive source of Clinical Trials.
The database covers planned, ongoing, completed and terminated/suspended/withdrawn clinical trials.
Clinical Trials database provides intelligence on global clinical trials for all indications. The data is sourced from:
- 250+ clinical trial registries
- 200+ scientific and investor conferences, company pipelines, press releases, and SEC filings.
Benefit
The Clinical Trials database collects information on various parameters to provide a Clinical Trial overview as well as Clinical Trial details, Drug details, Patient details, Trial Results, Location(s)/Sponsor(s) and Contact Detail(s).
Access:
- Detailed trial information.
- Drug information.
- Patient information, including inclusion and exclusion criteria.
- Trial results, as reported in the public domain.
- Biomarkers used for patient stratification/selection & outcome measures.
- Enrolment parameters.
- Investigators involved in clinical trials.
- Trials sites and locations.
- Contact information.
Value
Competitive Activity – keep an eye on planned or ongoing trials, as well as the trials currently recruiting and who is sponsoring them.
Geographic Analysis - see where trials are being run.
Trend Analysis - view top sponsors, indications, phase, status and more with Trial Analytics.
Find information on trials contacts, as well as Site and Investigator information.
Get information on trial successes and failures.
Get intelligence on CROs engaged in clinical trials.
Use as a business development tool for CROs.
Premium databases is part of our industry range of products
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer